What is it about?

Neurofibromatosis type 1 (NF1) is a rare genetic condition with an estimated prevalence of 1 in 3,000 live births. It can affect the skin, bones, and nervous system. Symptoms vary widely—from a few skin spots to multiple tumors—and its progression is unpredictable. To better understand how people live with NF1, we conducted a qualitative study involving 38 Brazilian adults diagnosed with the condition. Participants answered open-ended questions about how NF1 has impacted their lives. Many shared experiences of fear and emotional distress related to the uncertainty of symptoms and future health outcomes. Common concerns included having children, the risk of passing on the condition, and the emotional challenges of parenting a child with NF1. Participants also reported pain, stigma, and difficulties in accessing adequate healthcare. Some coped through strategies such as avoidance or faith, while others demonstrated resilience in facing a lifelong condition with no known cure.

Featured Image

Why is it important?

Although the medical features of NF1 are relatively well documented, less is known about how individuals emotionally experience and manage the condition. In Brazil, as in many parts of the world, people living with NF1 often report feeling isolated, uncertain, and lacking access to reliable information and support. Understanding how individuals navigate life with NF1 sheds light on the emotional and psychological toll of the condition. This knowledge is essential for shaping healthcare practices that go beyond clinical treatment, offering emotional support and empowering individuals to adapt, cope, and maintain their quality of life.

Perspectives

Conducting this qualitative study on the lived experiences of adults with NF1 was an eye-opening journey. Listening to the voices of those who face daily uncertainty and emotional hardship due to a condition often misunderstood or overlooked in healthcare made this research especially meaningful. I hope it encourages more compassionate conversations between patients and healthcare professionals, and inspires future research that prioritizes the psychological and emotional dimensions of living with rare diseases.

Roberta Moraes
Universidade Federal de Sao Carlos

Read the Original

This page is a summary of: A qualitative approach to life with neurofibromatosis type 1 based on Mishel's Uncertainty in Illness Theory: “My body is a ticking time bomb”, Journal of Genetic Counseling, April 2025, Wiley,
DOI: 10.1002/jgc4.70006.
You can read the full text:

Read

Contributors

The following have contributed to this page